DMRA insider trading — Damora Therapeutics, Inc.
Over the last 90 days, insiders at Damora Therapeutics, Inc. (DMRA) made 1 open-market purchase worth $253K and 0 open-market sales worth $0, making them net buyers by $253K. The largest purchase was by Jarrett Jennifer (Director, President and CEO), who bought 12,500 shares for $253K on Sep 25, 2026.
Updated Oct 16, 2026.
Recent DMRA insider transactions
Every Form 4 filed by Damora Therapeutics, Inc. officers, directors and 10% owners in the last 90 days, newest first. P = open-market purchase, S = open-market sale; other codes are awards, option exercises, tax withholding or gifts.
| Trade date | Insider | Role | Type | Ownership | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| Sep 25, 2026 | Jarrett Jennifer | Director, President and CEO | P · Purchase | Direct | 12,500 | $20.23 | $253K | Form 4 |
DMRA insider trading FAQ
Are insiders buying DMRA stock?
Yes. In the last 90 days, Damora Therapeutics, Inc. insiders made 1 open-market purchase totaling $253K, and no open-market sales. Purchases with the insider's own money are generally seen as a stronger signal than sales, which happen for many reasons (taxes, diversification, planned 10b5-1 sales).
Who are the insiders trading DMRA?
Recent buyers: Jarrett Jennifer.
Where does DMRA insider trading data come from?
Every transaction comes from SEC Form 4 filings on EDGAR. Company officers, directors and 10% owners must file a Form 4 within two business days of buying or selling. InsiderBolt reads these filings directly from the SEC.
More stocks with insider activity
Insider trading data is for informational purposes only and is not investment advice. Filings can be amended; always confirm details on SEC EDGAR.